Form D — ImmuneBridge Inc.

0001960306-25-000003 · filed Apr 2, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06b
Reported offering amount: $7,132,000
Reported amount sold: $5,632,000
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: ImmuneBridge Inc.
CIK: 1960306
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: 2022
Address: 2122 BRYANT ST
SAN FRANCISCO, CA 94110
Phone: 415-527-5634

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Stuart Alexander Jacobson · Executive Officer

San Francisco, CA Find on LinkedIn ↗
Dylan Morris · Director

New York, NY Find on LinkedIn ↗
Nadiya Ishnazarova · Director

Amsterdam, P7 Find on LinkedIn ↗
Omri Amirav-Drory · Director

San Francisco, CA Find on LinkedIn ↗
Thomas Farrell · Director

San Francisco, CA Find on LinkedIn ↗
Alicia Jackson · Director

San Francisco, CA Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗